Self-adjusting insulin proves promising for type 1 diabetics

Jessica-stormlover

Diamond Member
Oct 4, 2021
2,978
3,434
1,938
Self-adjusting insulin proves promising for type 1 diabetics
By Paul McClure
April 18, 2023
Type 1 diabetics must constantly control their blood glucose with insulin. It’s a Goldilocks-type situation: administer too much insulin, and they risk low blood glucose (hypoglycemia), while too little can lead to high blood glucose (hyperglycemia). Researchers have developed a self-adjusting nanoparticle-based insulin formulation that may go some way towards improving blood glucose control.

Type 1 diabetes (T1D) is an autoimmune disease where the body’s immune system attacks the insulin-producing beta cells of the pancreas so that little or no insulin is produced. The exact cause of T1D is unknown but is thought to be due to genetics and some viruses.

Treatment of T1D requires taking fast-acting insulin, either by intermittent, manual injections or continuously via an insulin pump, and regularly monitoring blood glucose levels to avoid hypo- and hyperglycemia, both of which can have life-threatening consequences. Long-acting insulin might also be used to provide a slow, steady release of insulin.

This will also go along ways in saving lives. ;)
 
Jesus, I cannot believe what I see. Stormfront Lover has actually posted something that is not creepy and offensive! Good job.
 

Similar threads

Forum List

Back
Top